Abstract

This invention discloses methods for producing modified cellulose, modified nanocellulose, modified nanocellulose functionalized with other functional species, and derivatives thereof. The present invention also provides cellulose, nanocellulose, and their derivatives that are safe to use inside an animal or human body and are biocompatible without costly purification. These cellulose or nanocellulose materials can be used in many different applications, including carrier for pharmaceutical active agents and other medical devices.

IPC Classes  ?

• C08B 3/06 - Cellulose acetate
• C08B 3/08 - Preparation of cellulose esters of organic acids of monobasic organic acids with three or more carbon atoms
• C08B 15/02 - OxycelluloseHydrocelluloseCellulose hydrate
• C08B 15/04 - Carboxycellulose, e.g. prepared by oxidation with nitrogen dioxide
• C08B 15/05 - Derivatives containing elements other than carbon, hydrogen, oxygen, halogen, or sulfur
• C08L 1/02 - CelluloseModified cellulose
• B82Y 30/00 - Nanotechnology for materials or surface science, e.g. nanocomposites
• B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glasswareDroppers
• F15D 1/00 - Influencing the flow of fluids
• B65G 27/16 - Applications of devices for generating or transmitting jigging movements of vibrators, i.e. devices for producing movements of high frequency and small amplitude
• A23L 29/262 - CelluloseDerivatives thereof, e.g. ethers
• A23D 9/007 - Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides

Abstract

This invention discloses methods for producing modified cellulose, modified nanocellulose, modified nanocellulose functionalized with other functional species, and derivatives thereof. The present invention also provides cellulose, nanocellulose, and their derivatives that are safe to use inside an animal or human body and are biocompatible without costly purification. These cellulose or nanocellulose materials can be used in many different applications, including carrier for pharmaceutical active agents and other medical devices.

IPC Classes  ?

• C08B 15/02 - OxycelluloseHydrocelluloseCellulose hydrate
• C08B 15/05 - Derivatives containing elements other than carbon, hydrogen, oxygen, halogen, or sulfur
• C08B 3/06 - Cellulose acetate
• C08B 15/04 - Carboxycellulose, e.g. prepared by oxidation with nitrogen dioxide
• A23L 29/262 - CelluloseDerivatives thereof, e.g. ethers
• A23D 9/007 - Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides

Abstract

This invention discloses methods for producing modified cellulose, modified nanocellulose, modified nanocellulose functionalized with other functional species, and derivatives thereof. The present invention also provides cellulose, nanocellulose, and their derivatives that are safe to use inside an animal or human body and are biocompatible without costly purification. These cellulose or nanocellulose materials can be used in many different applications, including carrier for pharmaceutical active agents and other medical devices.

IPC Classes  ?

• A23L 29/262 - CelluloseDerivatives thereof, e.g. ethers
• A23L 33/24 - Cellulose or derivatives thereof

Abstract

This invention discloses methods for producing modified cellulose, modified nanocellulose, modified nanocellulose functionalized with other functional species, and derivatives thereof. The present invention also provides cellulose, nanocellulose, and their derivatives that are safe to use inside an animal or human body and are biocompatible without costly purification. These cellulose or nanocellulose materials can be used in many different applications, including carrier for pharmaceutical active agents and other medical devices.

IPC Classes  ?

• A23L 29/262 - CelluloseDerivatives thereof, e.g. ethers
• A23L 33/24 - Cellulose or derivatives thereof
• B01F 17/48 - Cellulose ethers